ADDEX PHARMACEUTICALS | 5,516 Euro | -0,191 -3,35 % | |
| WKN: A0MSH6 ISIN: CH0029850754 Ticker-Symbol: APE | Frankfurt | 10.02.12 | 17:07 Uhr |
Branche PharmaAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 10.02. | Addex Pharmaceuticals: Addex to Present at the BIO CEO & Investor Conference | 60 | Thomson Reuters ONE | |
| Addex Pharmaceuticals /
Addex to Present at the BIO CEO & Investor Conference
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.... Mehr lesen zu: Addex Pharmaceuticals: Addex to Present at the BIO CEO & Investor Conference | ||||
| 10.02. | Addex Pharmaceuticals: Addex to Present at the BIO CEO & Investor Conf... | - | InvestEgate | |
| 28.11. | Addex: Fortschritt in der Diabetesforschung | 113 | BörseGo | |
| Genf (Godmode-Trader.ch) - Addex Pharmaceuticals ist bei der Forschung mit Peptiden einen Schritt vorangekommen. Das Biopharmaunternehmen teilte am Montag mit, man habe eine Interaktion zwischen einem... Mehr lesen zu: Addex: Fortschritt in der Diabetesforschung | ||||
| 28.11. | Addex: Forschungsfortschritt im Bereich Peptide | 84 | Moneycab | |
| Addex-CEO Bharatt Chowrira. Plan-les-Ouates - Das Biopharma-Unternehmen Addex hat im Bereich der Forschung mit Peptiden einen Fortschritt erzielt. Bei der Entdeckung geht es um eine neuartige Interaktion... Mehr lesen zu: Addex: Forschungsfortschritt im Bereich Peptide | ||||
| 28.11. | Addex Pharmaceuticals: Addex Scientists Discover Glucagon-like-peptide-1 (GLP-1) Induced Interaction Between GLP-1 and Gastric Inhibitory Peptide (GIP) Receptors | 55 | Thomson Reuters ONE | |
| Addex Pharmaceuticals /
Addex Scientists Discover Glucagon-like-peptide-1 (GLP-1) Induced Interaction
Between GLP-1 and Gastric Inhibitory Peptide (GIP) Receptors
. Processed and transmitted by Thomson... Mehr lesen zu: Addex Pharmaceuticals: Addex Scientists Discover Glucagon-like-peptide-1 (GLP-1) Induced Interaction Between GLP-1 and Gastric Inhibitory Peptide (GIP) Receptors | ||||
| 02.11. | Addex Pharmaceuticals: Addex Presents Data on Allosteric Modulators of GPCRs at the Discovery on Target Conference | 62 | Thomson Reuters ONE | |
| Addex Pharmaceuticals /
Addex Presents Data on Allosteric Modulators of GPCRs at the Discovery on
Target Conference
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible... Mehr lesen zu: Addex Pharmaceuticals: Addex Presents Data on Allosteric Modulators of GPCRs at the Discovery on Target Conference | ||||
| 24.10. | Addex Pharmaceuticals: Addex to Present at the BIO Investor Forum in San Francisco | 63 | Thomson Reuters ONE | |
| Addex Pharmaceuticals /
Addex to Present at the BIO Investor Forum in San Francisco
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.... Mehr lesen zu: Addex Pharmaceuticals: Addex to Present at the BIO Investor Forum in San Francisco | ||||
| 19.10. | Addex Pharmaceuticals: Addex to Present in NYC at the Newsmakers in the Biotech Industry conference hosted by BioCentury and Thomson Reuters | 39 | Thomson Reuters ONE | |
| Addex Pharmaceuticals /
Addex to Present in NYC at the Newsmakers in the Biotech Industry conference
hosted by BioCentury and Thomson Reuters
. Processed and transmitted by Thomson Reuters ONE.
The... Mehr lesen zu: Addex Pharmaceuticals: Addex to Present in NYC at the Newsmakers in the Biotech Industry conference hosted by BioCentury and Thomson Reuters | ||||
| 03.10. | Addex Pharmaceuticals: Addex to Present Progress on Multiple Allosteric Modulator Programs for Neurodegenerative and other Neurological Disorders | 62 | Thomson Reuters ONE | |
| Addex Pharmaceuticals /
Addex to Present Progress on Multiple Allosteric Modulator Programs for
Neurodegenerative and other Neurological Disorders
. Processed and transmitted by Thomson Reuters ONE.
The... Mehr lesen zu: Addex Pharmaceuticals: Addex to Present Progress on Multiple Allosteric Modulator Programs for Neurodegenerative and other Neurological Disorders | ||||
| 26.09. | Addex Pharmaceuticals: Addex to Present at the Jefferies 2011 Global Healthcare Conference in London | 57 | Thomson Reuters ONE | |
| Addex Pharmaceuticals /
Addex to Present at the Jefferies 2011 Global Healthcare Conference in London
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content... Mehr lesen zu: Addex Pharmaceuticals: Addex to Present at the Jefferies 2011 Global Healthcare Conference in London | ||||
| 02.09. | Addex Pharma To Regain All Rights To MGluR4 PAM Program From Merck | 221 | AFX News | |
| WHITEHOUSE STATION (dpa-AFX) - Addex Pharmaceuticals Ltd. (ADDXF.PK)
announced Friday that it will regain all rights to its metabotropic glutamate
receptor 4 or mGluR4 positive allosteric... Mehr lesen zu: Addex Pharma To Regain All Rights To MGluR4 PAM Program From Merck | ||||
| 02.09. | Addex Pharmaceuticals: Addex Regains Rights to Parkinson's Drug Candidates from Merck | 171 | Thomson Reuters ONE | |
| Addex Pharmaceuticals /
Addex Regains Rights to Parkinson's Drug Candidates from Merck
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.... Mehr lesen zu: Addex Pharmaceuticals: Addex Regains Rights to Parkinson's Drug Candidates from Merck | ||||
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
